These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 19180439)
1. [Comment from the family practice viewpoint]. Coradi B Praxis (Bern 1994); 2009 Feb; 98(3):131. PubMed ID: 19180439 [No Abstract] [Full Text] [Related]
6. Bringing JUPITER down to earth. Després JP Lancet; 2009 Apr; 373(9670):1147-8. PubMed ID: 19329179 [No Abstract] [Full Text] [Related]
7. JUPITER, rosuvastatin, and the European Medicines Agency. Ridker PM; Glynn RJ Lancet; 2010 Jun; 375(9731):2071. PubMed ID: 20494436 [No Abstract] [Full Text] [Related]
8. The numbers are in: statins for the primary prevention of cardiovascular disease in women. Duvernoy CS; Blumenthal R Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993 [No Abstract] [Full Text] [Related]
10. The editor's roundtable: the JUPITER trial--initial results and clinical implications. Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439 [No Abstract] [Full Text] [Related]
11. Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older. Ann Intern Med; 2010 Apr; 152(8):I34. PubMed ID: 20404365 [No Abstract] [Full Text] [Related]
12. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Ridker PM; Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996 [No Abstract] [Full Text] [Related]